Clinical Trials Browser

Phase 2 × Neoplasms, Basal Cell × 90 days × Clear all

NCT00833417 2026-05-11

A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma

Phase 2 Completed

104 enrolled 13 charts

Carcinoma, Basal Cell, Neoplasms, Basal Cell